07.12.2017 17:40:29

Las Vegas Sands Overweight

Der Analyst Barclays Capital hat das Kursziel für Las Vegas Sands Corp. von 69 auf 75 USD angehoben, aber die Einstufung auf "Overweight" belassen.
Zusammenfassung: Las Vegas Sands Corp. overweight
Unternehmen:
Las Vegas Sands Corp.
Analyst:
Barclays Capital
Kursziel:
$ 75,00
Rating jetzt:
overweight
Kurs*:
$ 69,11
Abst. Kursziel*:
8,52%
Rating update:
reiterated
Kurs aktuell:
$ 73,73
Abst. Kursziel aktuell:
1,72%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Analysen zu Las Vegas Sands Corp.mehr Analysen

26.04.18 Las Vegas Sands Market Perform Telsey Advisory Group
14.03.18 Las Vegas Sands Market Perform Telsey Advisory Group
25.01.18 Las Vegas Sands Buy Stifel, Nicolaus & Co., Inc.
07.12.17 Las Vegas Sands overweight Barclays Capital
26.10.17 Las Vegas Sands Buy Gabelli & Co

Eintrag hinzufügen

Aktien in diesem Artikel

Las Vegas Sands Corp. 62,89 0,79% Las Vegas Sands Corp.

Aktuelle Aktienanalysen

13.07.18 Apple market-perform Bernstein Research
13.07.18 Anthem Outperform BMO Capital Markets
13.07.18 Wright Medical Group Market Perform BMO Capital Markets
13.07.18 Glaukos Market Perform BMO Capital Markets
13.07.18 Broadcom Market Perform BMO Capital Markets
13.07.18 Stantec Outperform BMO Capital Markets
13.07.18 Fireman BV Registered Outperform BMO Capital Markets
13.07.18 Finisar Buy Cascend Securities
13.07.18 Citigroup Outperform RBC Capital Markets
13.07.18 Intel Sector Perform RBC Capital Markets
13.07.18 Amazon overweight Morgan Stanley
13.07.18 Amgen overweight Morgan Stanley
13.07.18 Childrens Place Retail Stores Outperform Wedbush Morgan Securities Inc.
13.07.18 McDonalds Hold Stifel, Nicolaus & Co., Inc.
13.07.18 Urban Outfitters Neutral Wedbush Morgan Securities Inc.
13.07.18 Intel Hold Stifel, Nicolaus & Co., Inc.
13.07.18 Alphabet A (ex Google) overweight Barclays Capital
13.07.18 Alphabet A (ex Google) buy Jefferies & Company Inc.
13.07.18 General Electric Underweight JP Morgan Chase & Co.
13.07.18 Facebook buy Jefferies & Company Inc.
13.07.18 Facebook overweight Barclays Capital
13.07.18 ExxonMobil buy HSBC
13.07.18 Amgen buy Jefferies & Company Inc.
13.07.18 Coca-Cola Hold Stifel, Nicolaus & Co., Inc.
13.07.18 Apple Neutral Nomura
13.07.18 Amazon overweight Barclays Capital
13.07.18 Amazon buy Jefferies & Company Inc.
13.07.18 HOCHTIEF Neutral Macquarie Research
13.07.18 Siltronic buy Citigroup Corp.
13.07.18 Infineon buy Citigroup Corp.
13.07.18 Perficient Buy Needham & Company, LLC
13.07.18 Aerie Pharmaceuticals Buy Needham & Company, LLC
13.07.18 JPMorgan Chase & Neutral Goldman Sachs Group Inc.
13.07.18 Enova International Buy Maxim Group
13.07.18 JPMorgan Chase & Outperform RBC Capital Markets
13.07.18 Verastem Buy BTIG Research
13.07.18 Zogenix Buy Stifel, Nicolaus & Co., Inc.
13.07.18 Align Technology Buy Stifel, Nicolaus & Co., Inc.
13.07.18 Bayer Equal weight Barclays Capital
13.07.18 HeidelbergCement overweight Barclays Capital
13.07.18 Galmed Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
13.07.18 SAP Equal-Weight Morgan Stanley
13.07.18 Wirecard Equal-Weight Morgan Stanley
13.07.18 Software Underweight Morgan Stanley
13.07.18 Fresenius Medical Care Equal weight Barclays Capital
13.07.18 HeidelbergCement buy Citigroup Corp.
13.07.18 LafargeHolcim buy Citigroup Corp.
13.07.18 METRO (St) Equal weight Barclays Capital
13.07.18 Spirit Airlines Outperform Imperial Capital
13.07.18 Delta Air Lines Outperform Imperial Capital